Your browser doesn't support javascript.
loading
Unbiased proteomic profiling of host cell extracellular vesicle composition and dynamics upon HIV-1 infection.
Martin-Jaular, Lorena; Nevo, Nathalie; Schessner, Julia P; Tkach, Mercedes; Jouve, Mabel; Dingli, Florent; Loew, Damarys; Witwer, Kenneth W; Ostrowski, Matias; Borner, Georg H H; Théry, Clotilde.
Afiliação
  • Martin-Jaular L; INSERM U932, Institut Curie Centre de Recherche, PSL Research University, Paris, France.
  • Nevo N; INSERM U932, Institut Curie Centre de Recherche, PSL Research University, Paris, France.
  • Schessner JP; Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany.
  • Tkach M; INSERM U932, Institut Curie Centre de Recherche, PSL Research University, Paris, France.
  • Jouve M; CNRS UMR3215, Institut Curie, PSL Research University, Paris, France.
  • Dingli F; Institut Curie, Centre de Recherche, Laboratoire de Spectrométrie de Masse Protéomique, PSL Research University, Paris, France.
  • Loew D; Institut Curie, Centre de Recherche, Laboratoire de Spectrométrie de Masse Protéomique, PSL Research University, Paris, France.
  • Witwer KW; Department of Molecular and Comparative Pathobiology and Department of Neurology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Ostrowski M; Instituto INBIRS, Universidad de Buenos Aires-CONICET, Buenos Aires, Argentina.
  • Borner GHH; Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany.
  • Théry C; INSERM U932, Institut Curie Centre de Recherche, PSL Research University, Paris, France.
EMBO J ; 40(8): e105492, 2021 04 15.
Article em En | MEDLINE | ID: mdl-33709510
ABSTRACT
Cells release diverse types of extracellular vesicles (EVs), which transfer complex signals to surrounding cells. Specific markers to distinguish different EVs (e.g. exosomes, ectosomes, enveloped viruses like HIV) are still lacking. We have developed a proteomic profiling approach for characterizing EV subtype composition and applied it to human Jurkat T cells. We generated an interactive database to define groups of proteins with similar profiles, suggesting release in similar EVs. Biochemical validation confirmed the presence of preferred partners of commonly used exosome markers in EVs CD81/ADAM10/ITGB1, and CD63/syntenin. We then compared EVs from control and HIV-1-infected cells. HIV infection altered EV profiles of several cellular proteins, including MOV10 and SPN, which became incorporated into HIV virions, and SERINC3, which was re-routed to non-viral EVs in a Nef-dependent manner. Furthermore, we found that SERINC3 controls the surface composition of EVs. Our workflow provides an unbiased approach for identifying candidate markers and potential regulators of EV subtypes. It can be widely applied to in vitro experimental systems for investigating physiological or pathological modifications of EV release.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / Proteoma / Vesículas Extracelulares Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / Proteoma / Vesículas Extracelulares Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article